Sri Harsha Paladugu is addressing the high failure rate of drugs in clinical trials by re-imagining human drug testing using more human-centric models, particularly the Multiple-Organs-on-Chip (MoC) technology. This innovative approach aims to better mimic human physiology, enhance drug safety, and expedite the drug development process, with a current focus on understanding and combatting the complex process of cancer metastasis in breast cancer.

Further Activities to have a look at